Morphosis Capital
Overview
Morphosis Capital is a private equity firm established in 2018 by four Romanian entrepreneurs: Simona Gemeneanu, Gabriela Dumitru, Dragoș Petre, and Andrei Gemeneanu. The firm aims to contribute to the development and transformation of Romanian SMEs into regional players. In September 2025, Morphosis Capital closed its second fund, Morphosis Capital Fund II, at €130 million, surpassing its initial target of €100 million. The fund secured commitments from major institutional backers, including the European Investment Fund (EIF), the European Bank for Reconstruction and Development (EBRD), and the International Finance Corporation (IFC). Over €50 million was also contributed by successful Western European entrepreneurs, underscoring a blended LP base of institutional stability and entrepreneurial spirit. The firm targets SMEs with EBITDA between €1 million and €5 million, typically businesses with strong local foundations and clear opportunities for regional expansion. Sector priorities include healthcare, B2B services, consumer products, retail, and niche manufacturing. Morphosis seeks to back companies with both commercial strength and the ability to deliver long-term social or ecosystem impact.
Investment Focus
- EBITDA between €1 million and €5 million
- Strong local foundations
- Clear opportunities for regional expansion
Portfolio Companies
Reach Morphosis Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Morphosis Capital
What sectors does Morphosis Capital invest in?
Morphosis Capital invests in Healthcare, Retail, Consumer Products, B2B Services and Niche Manufacturing, and is based in 25 Sectorul 1, Romania. Morphosis Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Morphosis Capital invest at?
Morphosis Capital backs companies at Growth and Buyout, writing cheques of 10M - 15M.
Which regions does Morphosis Capital invest in?
Morphosis Capital invests across Croatia, Poland, Czech Republic, Slovakia, Romania and Bulgaria.
Who are the partners at Morphosis Capital?
Team members listed for Morphosis Capital include Victor Razvan Visan (Limited Partner) and Constantin Stan (Founder).
What companies has Morphosis Capital invested in?
Morphosis Capital's portfolio includes DocProcess, Medima Health, EMI, Cronos Med, Stay Fit Gym, La Cocos, Mark Twain International School and EnduroSat.
How do I contact Morphosis Capital?
Morphosis Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
